Anchor Capital Advisors LLC Abb Vie Inc. Transaction History

Anchor Capital Advisors LLC

$3.51 Billion
Q3 2024

A detailed history of Anchor Capital Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Anchor Capital Advisors LLC holds 95,498 shares of ABBV stock, worth $15.8 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

95,498

Previous 96,566 1.11%

Holding current value

$15.8 Million

Previous $16.6 Million 13.86%

% of portfolio

0.54%

Previous 0.48%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$163.84 - $199.33 $174,981 - $212,884	-1,068 Reduced 1.11%	95,498 $18.9 Million
Q2 2024 Aug 06, 2024	BUY	$154.79 - $180.76 $108,817 - $127,074	703 Added 0.73%	96,566 $16.6 Million
Q1 2024 May 07, 2024	SELL	$159.82 - $182.1 $1.81 Million - $2.07 Million	-11,353 Reduced 10.59%	95,863 $17.5 Million
Q4 2023 Feb 05, 2024	SELL	$137.6 - $154.97 $230,204 - $259,264	-1,673 Reduced 1.54%	107,216 $16.6 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $269,317 - $311,774	-2,016 Reduced 1.82%	108,889 $16.2 Million
Q2 2023 Aug 04, 2023	BUY	$132.51 - $164.9 $271,910 - $338,374	2,052 Added 1.89%	110,905 $14.9 Million
Q1 2023 May 03, 2023	BUY	$144.61 - $166.54 $536,358 - $617,696	3,709 Added 3.53%	108,853 $17.3 Million
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $976,191 - $1.17 Million	-7,058 Reduced 6.29%	105,144 $17 Million
Q3 2022 Nov 09, 2022	SELL	$134.21 - $153.93 $843,778 - $967,757	-6,287 Reduced 5.31%	112,202 $15.1 Million
Q2 2022 Aug 04, 2022	BUY	$137.62 - $174.96 $15.7 Million - $19.9 Million	113,913 Added 2489.36%	118,489 $18.1 Million
Q4 2021 Feb 10, 2022	SELL	$107.43 - $135.93 $21,486 - $27,186	-200 Reduced 4.19%	4,576 $620,000
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $10,521 - $11,721	-100 Reduced 2.05%	4,776 $538,000
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $10,230 - $11,262	-100 Reduced 2.01%	4,876 $528,000
Q2 2020 Aug 10, 2020	SELL	$73.37 - $98.18 $2,274 - $3,043	-31 Reduced 0.62%	4,976 $489,000
Q1 2020 May 07, 2020	SELL	$64.5 - $97.79 $3,225 - $4,889	-50 Reduced 0.99%	5,007 $381,000
Q4 2019 Jan 27, 2020	SELL	$72.13 - $90.25 $2,308 - $2,888	-32 Reduced 0.63%	5,057 $448,000
Q3 2019 Oct 25, 2019	SELL	$62.98 - $75.72 $25,380 - $30,515	-403 Reduced 7.34%	5,089 $385,000
Q2 2019 Aug 01, 2019	SELL	$65.7 - $83.98 $92,308 - $117,991	-1,405 Reduced 20.37%	5,492 $399,000
Q1 2019 May 09, 2019	SELL	$77.14 - $90.79 $75,828 - $89,246	-983 Reduced 12.47%	6,897 $556,000
Q4 2018 Feb 04, 2019	SELL	$77.85 - $96.01 $46,710 - $57,606	-600 Reduced 7.08%	7,880 $726,000
Q2 2018 Aug 07, 2018	SELL	$89.78 - $106.23 $1 Million - $1.19 Million	-11,188 Reduced 56.88%	8,480 $786,000
Q1 2018 May 09, 2018	BUY	$92.01 - $123.21 $979,262 - $1.31 Million	10,643 Added 117.93%	19,668 $1.86 Million
Q3 2017 Nov 06, 2017	BUY	$69.85 - $89.22 $630,396 - $805,210	9,025	9,025 $802,000

Others Institutions Holding ABBV

# of Institutions

3,841

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $292B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Anchor Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Anchor Capital Advisors LLC with notifications on news.

Account

Anchor Capital Advisors LLC Abb Vie Inc. Transaction History